Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice.
Atopic dermatitis
Children
Corticophobia
Corticosteroids
Pediatric
Side effects
Topical therapy
Journal
Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
08
04
2020
revised:
27
04
2020
accepted:
28
04
2020
pubmed:
18
5
2020
medline:
4
6
2021
entrez:
18
5
2020
Statut:
ppublish
Résumé
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disease, affecting up to 25% of children. Topical corticosteroids (TCS) are currently used as first-line antiinflammatory treatment for AD, due to their overall therapeutic efficacy, and the availability of different potency classes and a wide array of formulations. Therapeutic efficacy of TCS depends upon selecting the appropriate vehicle and potency, and the frequency of application, also taking into account the duration of treatment and patient preferences. This article focuses on TCS benefits and potential risks and it provides practical tips to properly use these drugs in clinical practice, to make a patient-tailored treatment approach.
Identifiants
pubmed: 32417503
pii: S1043-6618(20)31186-5
doi: 10.1016/j.phrs.2020.104878
pii:
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Anti-Allergic Agents
0
Anti-Inflammatory Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
104878Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.